SP, A., AM, M., R, L., MA, M., DE, N., S, P., . . . G, K. (2016). A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men. The Journal of infectious diseases, 214(9), 1341. https://doi.org/10.1093/infdis/jiw365
Chicago Style (17th ed.) CitationSP, Adler, et al. "A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men." The Journal of Infectious Diseases 214, no. 9 (2016): 1341. https://doi.org/10.1093/infdis/jiw365.
MLA (9th ed.) CitationSP, Adler, et al. "A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men." The Journal of Infectious Diseases, vol. 214, no. 9, 2016, p. 1341, https://doi.org/10.1093/infdis/jiw365.